PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1150 (113th)

Preservation of Antibiotics for Medical Treatment Act of 2013

referredUnited States· United States Congress· EN

Introduced

14 March 2013

Last action

15 March 2013 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

LOUISE SLAUGHTER, Rosa DeLauro, JAMES LANGEVIN, Rep. DeGette, Diana [D-CO-1], Barbara Lee, Rep. Rangel, Charles B. [D-NY-19], Grace Napolitano, Gerald Connolly, CAROLYN MALONEY, Rep. Holt, Rush [D-NJ-12], Rep. Moore, Gwen [D-WI-4], Rep. Kaptur, Marcy [D-OH-9], Rep. Clarke, Yvette D. [D-NY-9], Rep. Lofgren, Zoe [D-CA-18], James Himes, Rep. Moran, James P. [D-VA-8], Rep. Waxman, Henry A. [D-CA-24], Rick Larsen, DAVID PRICE, Rep. McCollum, Betty [D-MN-4], Rep. Pingree, Chellie [D-ME-1], Rep. Michaud, Michael H. [D-ME-2], Rep. Miller, George [D-CA-7], PETER DEFAZIO, Daniel Lipinski, Raúl Grijalva, Sen. Welch, Peter [D-VT], Jackie Speier, ALCEE HASTINGS, Carol Shea-Porter, Del. Bordallo, Madeleine Z. [D-GU-At Large], Rep. Farr, Sam [D-CA-20], Rep. Tierney, John F. [D-MA-6], Donald Payne, Rep. Chu, Judy [D-CA-28], Anna Eshoo, Rep. Hahn, Janice [D-CA-44], Matt Cartwright, Earl Blumenauer, SANDER LEVIN, Rep. Schakowsky, Janice D. [D-IL-9], David Cicilline, John Larson, Sen. Markey, Edward J. [D-MA], Rep. Huffman, Jared [D-CA-2], BOBBY RUSH, James McGovern, Keith Ellison

Subjects

Healthcare

Source updated

6 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Preservation of Antibiotics for Medical Treatment Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to require an applicant for approval of a new animal drug that is a medically important antimicrobial to demonstrate that there is a reasonable certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Requires the Secretary of Health and Human Services (HHS) to refuse approval if the applicant fails to make such a demonstration. Defines “medically important antimicrobial” as a drug intended for use in food-producing animals and composed wholly or partly of: (1) any kind of specified antibiotics, including penicillin and tetracycline; or (2) a drug from an antimicrobial class that is listed on the World Health Organization’s list of critically important antimicrobials. Requires the Secretary to withdraw approval for the nontherapeutic use in food-producing animals of a medically important antimicrobial marketed for human use unless the Secretary makes a final written determination that, based on either the application holder's demonstration or an HHS risk analysis, there is a reasonable certainty of no harm to human health due to the development of antimicrobial resistance attributable to the drug's nontherapeutic use. Requires the Secretary to rescind approval of an exemption for investigational use of, or of approval of a new drug application for, a medically important antimicrobial for its nontherapeutic use in a food-producing animal two years after the exemption is granted or the application for approval is submitted. Exempts from this requirement any drugs for which there has been found a reasonable certainty of no harm to human health. Prohibits the administration of a medically important antimicrobial (including by means of animal feed) to a food-producing animal for nonroutine disease control unless there is a significant risk that a disease or infection present on the premises will be transmitted to the food-producing animal. Requires the administration of the antimicrobial to be: (1) necessary to prevent or reduce the risk of transmission; (2) for the shortest duration possible to prevent or reduce the risk of transmission; and (3) at a scale no greater than the barn, house, or pen level and to the fewest animals possible to prevent or reduce the risk of transmission.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 14 March 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  2. 14 March 2013

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  3. 14 March 2013

    Introduced

    Sponsor introductory remarks on measure. (CR E299)

    Source: IntroReferral

  4. 14 March 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 15 March 2013

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Showing 48 of 80 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.